A study aiming to evaluate the effects of this compound on lipolysis, obesity, and the browning of human white adipocytes showed that EGCG can significantly reduce systolic and diastolic blood pressure (p < 0.05), fasting plasma triglyceride levels (p < 0.05), and serum kisspeptin levels (p < 0.05) after eight weeks of supplementation [359]. This evidence concerns the gene KISS1 and obesity disorder.